rs141475605
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_006947.4(SRP72):c.191C>T(p.Ala64Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000248 in 1,612,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006947.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRP72 | NM_006947.4 | c.191C>T | p.Ala64Val | missense_variant | Exon 2 of 19 | ENST00000642900.1 | NP_008878.3 | |
SRP72 | NM_001267722.2 | c.191C>T | p.Ala64Val | missense_variant | Exon 2 of 17 | NP_001254651.1 | ||
SRP72 | XM_024454192.2 | c.191C>T | p.Ala64Val | missense_variant | Exon 2 of 17 | XP_024309960.1 | ||
SRP72 | NR_151856.2 | n.210C>T | non_coding_transcript_exon_variant | Exon 2 of 20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRP72 | ENST00000642900.1 | c.191C>T | p.Ala64Val | missense_variant | Exon 2 of 19 | NM_006947.4 | ENSP00000495128.1 | |||
SRP72 | ENST00000510663.6 | c.191C>T | p.Ala64Val | missense_variant | Exon 2 of 17 | 1 | ENSP00000424576.1 | |||
SRP72 | ENST00000505314.2 | c.89C>T | p.Ala30Val | missense_variant | Exon 2 of 12 | 3 | ENSP00000425190.3 | |||
SRP72 | ENST00000504757.2 | c.191C>T | p.Ala64Val | missense_variant | Exon 2 of 5 | 2 | ENSP00000473576.1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000915 AC: 23AN: 251302Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135848
GnomAD4 exome AF: 0.000265 AC: 387AN: 1460266Hom.: 0 Cov.: 30 AF XY: 0.000255 AC XY: 185AN XY: 726472
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152312Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:2
- -
The p.A64V variant (also known as c.191C>T), located in coding exon 2 of the SRP72 gene, results from a C to T substitution at nucleotide position 191. The alanine at codon 64 is replaced by valine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
not provided Uncertain:2
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in an individual with multiple myeloma, but also in healthy controls (PMID: 28404951); This variant is associated with the following publications: (PMID: 28369529, 27899666, 28404951) -
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 64 of the SRP72 protein (p.Ala64Val). This variant is present in population databases (rs141475605, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SRP72-related conditions. ClinVar contains an entry for this variant (Variation ID: 436861). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SRP72 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at